Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Financial Results and Interim Dividend
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences Ltd has informed exchanges that its Board of Directors meeting is scheduled for May 20, 2026. The meeting will consider and approve standalone and consolidated audited financial results for Q4 and the full financial year ended March 31, 2026. Additionally, the Board will consider declaration of interim dividend for FY 2026-27. The trading window has been closed since April 1, 2026, and will remain closed until 48 hours after the financial results are declared, in compliance with SEBI Insider Trading Regulations.
This is a routine Board meeting intimation announcing the date for Q4/FY2026 results and potential dividend declaration. Investors should expect the results announcement after the Board meeting on May 20, 2026, with trading window likely opening shortly thereafter.